JP Morgan Private Wealth Advisors’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-13,276
Closed -$254K 1964
2022
Q2
$254K Buy
13,276
+836
+7% +$15.8K ﹤0.01% 1733
2022
Q1
$248K Buy
+12,440
New +$251K ﹤0.01% 1834

Other funds holding PAHC

JP Morgan Private Wealth Advisors's PAHC Position: Q3 2022 in Review

JP Morgan Private Wealth Advisors sold out of Phibro Animal Health (PAHC) in Q3 2022, closing a stake of 13,276 shares — an estimated $254K sold.

JP Morgan Private Wealth Advisors first reported a position in PAHC in Q1 2022 and held it in 2 quarters. The position peaked at $254K in Q2 2022. 149 funds tracked by Wall St. Rank hold PAHC as of Q3 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Phibro Animal Health position as of Q3 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 13,276 Phibro Animal Health shares in Q3 2022, an estimated $254K.
  • JP Morgan Private Wealth Advisors first reported a position in Phibro Animal Health in Q1 2022 and held it in 2 quarters.
  • JP Morgan Private Wealth Advisors's Phibro Animal Health position peaked at $254K in Q2 2022.
  • 149 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2022, filed 4 Nov 2022.